NATERA INC (NTRA) Stock News
NASDAQ:NTRA - Nasdaq - US6323071042 - Common Stock - Currency: USD
NTRA Latest News, Press Relases and Analysis
Natera To Present Data from 8 Studies at 2025 AACR Annual Meeting
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to Turn Down
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
A revolution in oncology could help cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Exact Sciences (NASDAQ:EXAS) and its peers.
Natera, Inc. (NTRA): Among Stocks with Buy Ratings that Hedge Funds Love
We recently published a list of 15 Stocks with Buy Ratings that Hedge Funds Love. In this article, we are going to take a look at where Natera, Inc. (NASDAQ:NTRA) stands against other stocks with buy ratings that hedge funds love. The U.S. stock market has been in chaos ever since President Trump announced his […]
27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks
27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks
Stanley Druckenmiller is in an elite league of investors that includes the likes of Warren Buffett. While Druckenmiller closed the firm in 2010, the George Soros protégé is still investing through his family office, the Duquesne Family Office, making him a great model for investors to follow. Roughly 27.5% of Druckenmiller's portfolio is invested in three under-the-radar artificial intelligence (AI) stocks.
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
Why Is Natera (NTRA) Stock Soaring Today
Shares of genetic testing company Natera (NASDAQ:NTRA). jumped 5.2% in the afternoon session after stocks rebounded, following a broad-based sell-off the previous day. The Nasdaq was down 4%, while the S&P fell 2.7% as concerns over the ongoing trade war continued to spread. While those concerns haven't exactly disappeared, it's likely some investors looked to take positions in some of the beaten-down stocks, especially some of the high-quality names that got caught up in the sell-off.
Natera Expands Intellectual Property Portfolio With New Patents in Tumor-Informed MRD
Natera (NASDAQ:NTRA) Reports Bullish Q4, Guides for Strong Full-Year Sales
Genetic testing company Natera (NASDAQ:NTRA). reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 53% year on year to $476.1 million. The company’s full-year revenue guidance of $1.91 billion at the midpoint came in 5.8% above analysts’ estimates. Its GAAP loss of $0.41 per share was 9.3% below analysts’ consensus estimates.
Natera Reports Fourth Quarter and Full Year 2024 Financial Results
Natera Announces Medicare Coverage of Signatera™ for Surveillance in Lung Cancer
Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025
